2,5-Dioxopyrrolidin-1-yl 3-(3-methyl-3H-diazirin-3-yl)propanoate, 97%, 250mg

4-Nitroisoxazole, 95.0%, 1g

1,3-Dichloro-5-(3,3,3-trifluoroprop-1-en-2-yl)benzene, 97%, 100g

1-(3-Bromophenyl)-2,5-dimethyl-1H-pyrrole, 95.0%, 10g

N-Acetyl-L-tryptophanamide, 95.0%, 25g

Geldokumentationssystem gelLITE, UV-Transilluminator und Weißlichtkonverter 1 Stk

2-Bromo-1,1-(difluoroethyl)benzene, 97.0%, 1g

tert-butyl 4-[(2E)-3-(dimethylamino)prop-2-enoyl]piperidine-1-carboxylate, 100mg

4-(1,3-Oxazol-5-yl)benzonitrile, 95.0%, 10g

5-Chloromethyl-3-(3,4-dimethoxyphenyl)-[1,2,4]oxadiazole, 95.0%, 1g

2-Benzofurancarboxylic acid, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, ethyl ester, hydrochloride (1:2), 98%, 250mg

[(2S)-OXETAN-2-YL]METHANOL, 95%, 5g

DARIFENACIN HBR, 99%, 10mg